A single arm clinical study to evulate the efficacy of chitrakadi kwath in the management of pratham patalagata timir (simple myopia)

Kiran Sinhmar1 site in 1 country30 target enrollmentStarted: March 26, 2022Last updated: July 5, 2023

Trial Snapshot

Phase: Phase 2/3
Status: Completed
Sponsor
Enrollment: 30
Locations: 1
Primary Endpoint: To assess efficacy of chitarkadi kwath on distant visual acuity and refractive power of the myopic patients.

Study Overview Study Design Eligibility Criteria Outcomes Investigators Sites Records & Identifiers Similar Trials

Study Overview

Brief Summary

The aim of study is to see the effectiveness of chitrakadi kwath in management of pratham patalagata timir (simple myopia). The study will be conducted with 30 patients showing signs and symptoms of pratham patalagata timir ( simple myopia) they will be administered chitrakadi kwath with goghrita once in a night for 30 days and follow up will be done on 15 and 31 days and conclusion will be drawn on the basis on proper statistical methods.

Study Design

Study Type: Interventional
Allocation: Computer generated randomization
Masking: Open Label

Eligibility Criteria

Ages: 18.00 Year(s) to 40.00 Year(s) (—)
Sex: All

Inclusion Criteria

•All the patients presenting with sign and symptoms of pratham patalagata timir will be taken for clinical trials of either caste, religion, socioeconomic status 2)Individuals of either sex of age group between 18 to 40 years 3)Patients having myopia upto 5.0D ( Spherical) 4)Patients who are ready to sign informed concent form.

Exclusion Criteria

•Patients having other type of myopia 2)Patient having cataract and post operative cataract 3)Any inflammatory and traumatic conditions of eyes 4)Pregnant and lactating women 5)Myopia with systamic disease like TB,Hypertension, Diabetes Mellitus 6)Patients having more than -5D of refractive power 7)Patient who need surgical and other interventions 8)Patients with other eyes disease like glucoma(increased risk IOP), sceritis,conjunctivitis 9)History of genetic problems.

Outcomes

Primary Outcomes

To assess efficacy of chitarkadi kwath on distant visual acuity and refractive power of the myopic patients.

Time Frame: 30 days study with 2 follow ups (0,15,31 days)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor

Kiran Sinhmar

Sponsor Class

Other [self]

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting

Phase 2/3

Study held to see the effect of madanadi lepa in treatment of padadari(cracked feet)

CTRI/2020/11/029147Dr Puja Sanjay Wagh40

Not yet recruiting

Phase 2

Study the efficacy of phalatrikadi kwath in the management of non alcoholic fatty liver disease grade 1 and grade 2

CTRI/2023/05/053029TAPUBRATA BARUAH

Not yet recruiting

Phase 2/3

Study held to see the effect of intake of nagbala milk decoction in treatment of high blood pressure

CTRI/2020/11/028833Samkit Shah40

Not yet recruiting

Phase 3 4

Study held to see the Effect of trivrutadi oil matra basti (anal route administration of 60ml oil)in dysmenorrhea.

CTRI/2021/01/030504DrShobhna Shrivastava50

Not yet recruiting

Phase 2

clinical efficacy of Katphaladi Kwatha and shadbindu tail nasya in the management of Dushta Pratishyaya - chronic sinusitis

CTRI/2020/06/025585All India Institute of Ayurveda